Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats

Neuroscience Letters

Volumn 419, Issue 1, 2007, Pages 49-54

  Wei, Peng ^a   Liu, Jia ^a   Zhou, Hao Li ^a   Han, Zhi Tong ^a   Wu, Qing Ying ^a   Pang, Jiang Xia ^a   Liu, Su ^a   Wang, Ting Hua ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Green fluorescent protein transgenic mice; Neural stem cells; Parkinson's disease; Rat; Transplantation

Indexed keywords

GREEN FLUORESCENT PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; ENGRAFTMENT; EVALUATION; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; ANTIPARKINSON AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; STEREOTYPED BEHAVIOR; SYMPATHOLYTICS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TYROSINE 3-MONOOXYGENASE;

EID: 34248176431     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.03.046     Document Type: Article

References (30)

1. Bao X.M., and Shu S.Y. The Stereotaxic Atlas of the Rat Brain (1991), The People's Medical Publishing House, Beijing pp. 33-53
2. Barberi T., Klivenyi P., Calingasan N.Y., Lee H., Kawamata H., Loonam K., Perrier A.L., Bruses J., Rubio M.E., Topf N., Tabar V., Harrison N.L., Beal M.F., Moore M.A., and Studer L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotechnol. 21 (2003) 1200-1207
3. Barinaga M. Fetal neuron grafts pave the way for stem cell therapies. Science 287 (2000) 1421-1422
4. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2 (2001) 325-334
5. Ben-Hur T., Einstein O., Mizrachi-Kol R., Ben-Menachem O., Reinhartz E., Karussis D., and Abramsky O. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 41 (2003) 73-80
6. Ben-Hur T., Idelson M., Khaner H., Pera M., Reinhartz E., Itzik A., and Reubinoff B.E. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 22 (2004) 1246-1255
7. Bjorklund A., and Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3 (2000) 537-544
8. Bjorklund L.M., Sanchez-Pernaute R., Chung S., Andersson T., Chen I.Y., McNaught K.S., Brownell A.L., Jenkins B.G., Wahlestedt C., Kim K.S., and Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2344-2349
9. Branton R.L., and Clarke D.J. Apoptosis in primary cultures of E14 rat ventral mesencephala: time courses of dopaminergic cell death and implications for neural transplantation. Exp. Neurol. 160 (1999) 88-98
10. Chaturvedi R.K., Shukla S., Seth K., and Agrawal A.K. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Neurosci. Lett. 398 (2006) 44-49
11. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., and Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 4 (1998) 1313-1317
12. Espejo M., Cutillas B., Arenas T.E., and Ambrosio S. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant. 9 (2000) 45-53
13. Fred H.G. Mammalian neural stem cells. Science 287 (2000) 1433-1438
14. Freed C.R., Geene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., and Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 (2001) 710-719
15. Hefti F., Melamed E., Sahakian B.J., and Wurtman R.J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol. Biochem. Behav. 12 (1980) 185-188
16. Hughes A.J., Daniel S.E., Blankson S., and Lees A.J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neural. 50 (1993) 140-148
17. Jeong S.W., Chu K., Jung K.H., Kim S.U., Kim M., and Roh J.K. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34 (2003) 2258-2263
18. Karbanova J., Mokry J., and Kotingova L. Neural stem cells transplanted into intact brains as neurospheres form solid grafts composed of neurons, astrocytes and oligodendrocyte precursors. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 148 (2004) 217-220
19. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.H., Nguyen J., Sanchez-Pernaute R., Bankiewicz K., and McKay R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 (2003) 50-56
20. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., and McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18 (2000) 675-679
21. Lotharius J., and Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3 (2002) 932-942
22. Martinez-Serrano A., Rubio F.J., Navarro B., Bueno C., and Villa A. Human neural stem and progenitor cell: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr. Gene Ther. 1 (2001) 279-299
23. Ourednik J., Ourednik V., Lynch W.P., Schachner M., and Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20 (2002) 1103-1110
24. Quinn N.P. The clinical application of cell grafting techniques in patients with Parkinson's disease. Prog. Brain Res. 82 (1990) 619-625
25. Rakic P. Neuroscience: immigration denied. Nature 427 (2004) 685-686
26. Sanai N., Tramontin A.D., Quinones-Hinojosa A., Barbaro N.M., Gupta N., Kunwar S., Lawton M.T., McDermott M.W., Parsa A.T., Manuel-Garcia Verdugo J., Berger M.S., and Alvarez-Buylla A. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427 (2004) 740-744
27. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research: analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50 (1996) 275-331
28. Schwarting R.K., and Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog. Neurobiol. 49 (1996) 215-266
29. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24 (1970) 485-493
30. Wang H.M., Luo D.X., Wang Z.P., and Sun D.J. The relationship between Parkinson's disease and the production and Oxidation of free radicals. Zhongguo Linchuang Kangfu (Chin. J. Clin. Rehabil.). 6 (2002) 373